Esophageal temperature monitoring during heart ablation
Part of Heart & circulation clinical trials.
This study tests a new way to monitor the temperature in your esophagus during a standard heart ablation procedure for atrial fibrillation. The goal is to see if the new catheter (Q-DOT Micro) safely heats the heart tissue without harming the esophagus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes).
- You are scheduled for a first-time catheter ablation procedure to treat your atrial fibrillation (no prior ablation on the left side of your heart).
- You do not have any stomach or esophagus conditions that would make a capsule endoscopy unsafe.
- You are willing to sign a consent form and follow all study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a new type of energy called pulse field ablation (a procedure that uses short bursts of electric pulses) works as well as standard ablation for restoring normal heart rhythm in patients with episodes of irregular heartbeat. It may help your heart pump more normally.
This trial tests a new treatment that uses two types of energy (pulsed field and radiofrequency) to fix the heart's electrical signals in people with paroxysmal atrial fibrillation (AFib that comes and goes). It aims to be more effective and safer than standard ablation alone.
This trial tests three different ways of delivering radiofrequency energy using a specific catheter (QDOT) during a first-time procedure to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to find which method works best for patients with recent or short-lasting AF episodes.
This study tests a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which is used to treat atrial fibrillation (an irregular heartbeat). It aims to improve the accuracy of the treatment, which may help your heart stay in a normal rhythm for longer.
This trial tests a new device that monitors your breathing muscle (diaphragm) during a procedure to treat an irregular heartbeat called atrial fibrillation. The device may help doctors protect your diaphragm during the ablation procedure.
This study tests a new system (QDOT MICRO and VISITAG SURPOINT) used during a catheter ablation procedure to treat atrial fibrillation (AF). It aims to see how safe and effective it is over the long term for people whose AF comes and goes and hasn't been controlled by medication.
Hear when a new Atrial Fibrillation Paroxysmal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.